[1]
|
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E.C., Biryukov, S., Abbafati, C., Abera, S.F., et al. (2014) Global, Regional, and National Prevalence of Overweight and Obesity in Children and Adults during 1980-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. The Lancet, 384, 766-781.
https://doi.org/10.1016/S0140-6736(14)60460-8
|
[2]
|
Berrington de Gonzalez, A., Hartge, P., Cerhan, J.R., Flint, A.J., Hannan, L., MacInnis, R.J., Moore, S.C., Tobias, G.S., Anton-Culver, H., Freeman, L.B., Beeson, W.L., Clipp, S.L., English, D.R., Folsom, A.R., Freedman, D.M., Giles, G., Hakansson, N., Henderson, K.D., Hoffman-Bolton, J., Hoppin, J.A., Koenig, K.L., Lee, I.M., Linet, M.S., Park, Y., Pocobelli, G., Schatzkin, A., Sesso, H.D., Weiderpass, E., Willcox, B.J., Wolk, A., Zeleniuch-Jacquotte, A., Willett, W.C. and Thun, M.J. (2010) Body-Mass Index and Mortality among 1.46 Million White Adults. The New England Journal of Medicine, 363, 2211-2219. (Erratum in: N Engl J Med, 2011 Sep 1, 365(9): 869)
https://doi.org/10.1056/NEJMoa1000367
|
[3]
|
中国营养学会肥胖防控分会, 等. 中国居民肥胖防治专家共识[J]. 中国预防医学志, 2022, 23(5): 321-339.
https://doi.org/10.16506/j.1009-6639.2022.05.001
|
[4]
|
Safaei, M., Sundararajan, E.A., Driss, M., Boulila, W. and Shapi’i, A. (2021) A Systematic Literature Review on Obesity: Understanding the Causes & Consequences of Obesity and Reviewing Various Machine Learning Approaches Used to Predict Obesity. Computers in Biology and Medicine, 136, Article 104754.
https://doi.org/10.1016/j.compbiomed.2021.104754
|
[5]
|
Lee, Y.S., Wollam, J. and Olefsky, J.M. (2018) An Inte-grated View of Immunometabolism. Cell, 172, 22-40.
https://doi.org/10.1016/j.cell.2017.12.025
|
[6]
|
Blüher, M. (2020) Metabolically Healthy Obesity. Endocrine Re-views, 41, bnaa004.
https://doi.org/10.1210/endrev/bnaa004
|
[7]
|
Bala, C., Craciun, A.E. and Hancu, N. (2016) Updating the Concept of Metabolically Healthy Obesity. Acta Endocrinologica (Bucharest), 12, 197-205. https://doi.org/10.4183/aeb.2016.197
|
[8]
|
van Vliet-Ostaptchouk, J.V., Nuotio, M.L., Slagter, S.N., Doiron, D., Fischer, K., Foco, L., Gaye, A., Gögele, M., Heier, M., Hiekkalinna, T., Joensuu, A., Newby, C., Pang, C., Partinen, E., Reischl, E., Schwienbacher, C., Tammesoo, M.L., Swertz, M.A., Burton, P., Ferretti, V., Fortier, I., Giepmans, L., Harris, J.R., Hillege, H.L., Holmen, J., Jula, A., Kootstra-Ros, J.E., Kvaløy, K., Holmen, T.L., Männistö, S., Metspalu, A., Midthjell, K., Murtagh, M.J., Peters, A., Pramstaller, P.P., Saaristo, T., Salomaa, V., Stolk, R.P., Uusitupa, M., van der Harst, P., van der Klauw, M.M., Waldenberger, M., Perola, M. and Wolffenbuttel, B.H. (2014) The Prevalence of Meta-bolic Syndrome and Metabolically Healthy Obesity in Europe: A Collaborative Analysis of Ten Large Cohort Studies. BMC Endocrine Disorders, 14, Article No. 9. https://doi.org/10.1186/1472-6823-14-9
|
[9]
|
Rey-López, J.P., de Rezende, L.F., Pastor-Valero, M. and Tess, B.H. (2014) The Prevalence of Metabolically Healthy Obesity: A Systematic Review and Critical Evaluation of the Definitions Used. Obesity Reviews, 15, 781-790.
https://doi.org/10.1111/obr.12198
|
[10]
|
Lavie, C.J., Laddu, D., Arena, R., Ortega, F.B., Alpert, M.A. and Kushner, R.F. (2018) Healthy Weight and Obesity Prevention: JACC Health Promotion Series. Journal of the American College of Cardiology, 72, 1506-1531.
https://doi.org/10.1016/j.jacc.2018.08.1037
|
[11]
|
Kim, J.I., Huh, J.Y., Sohn, J.H., Choe, S.S., Lee, Y.S., Lim, C.Y., Jo, A., Park, S.B., Han, W. and Kim, J.B. (2015) Lipid-Overloaded Enlarged Adipocytes Provoke Insulin Resistance In-dependent of Inflammation. Molecular and Cellular Biology, 35, 1686-1699. https://doi.org/10.1128/MCB.01321-14
|
[12]
|
Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L. and Spiegel-man, B.M. (1995) Increased Adipose Tissue Expression of Tumor Necrosis Factor-Alpha in Human Obesity and Insulin Resistance. Journal of Clinical Investigation, 95, 2409-2415. https://doi.org/10.1172/JCI117936
|
[13]
|
Makki, K., Froguel, P. and Wolowczuk, I. (2013) Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines. ISRN Inflammation, 2013, Article ID: 139239.
https://doi.org/10.1155/2013/139239
|
[14]
|
Lee, Y.S. and Olefsky, J. (2021) Chronic Tissue Inflammation and Met-abolic Disease. Genes & Development, 35, 307-328. https://doi.org/10.1101/gad.346312.120
|
[15]
|
Ouchi, N., Par-ker, J.L., Lugus, J.J. and Walsh, K. (2011) Adipokines in Inflammation and Metabolic Disease. Nature Reviews Immu-nology, 11, 85-97. https://doi.org/10.1038/nri2921
|
[16]
|
Mulder, P., Morrison, M.C., Verschuren, L., Liang, W., van Bockel, J.H., Kooistra, T., Wielinga, P.Y. and Kleemann, R. (2016) Reduction of Obesity-Associated White Adipose Tissue Inflammation by Rosiglitazone Is Associated with Reduced Non-Alcoholic Fatty Liver Disease in LDLr-Deficient Mice. Scientific Reports, 6, Article No. 31542.
https://doi.org/10.1038/srep31542
|
[17]
|
Cawthorn, W.P. and Sethi, J.K. (2008) TNF-Alpha and Adipocyte Biology. FEBS Letters, 582, 117-131.
https://doi.org/10.1016/j.febslet.2007.11.051
|
[18]
|
Qatanani, M. and Lazar, M.A. (2007) Mechanisms of Obesi-ty-Associated Insulin Resistance: Many Choices on the Menu. Genes & Development, 21, 1443-1455. https://doi.org/10.1101/gad.1550907
|
[19]
|
Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L. and Ferrante Jr., A.W. (2003) Obesity Is Associated with Macrophage Accumulation in Adipose Tissue. Journal of Clinical Investigation, 112, 1796-1808.
https://doi.org/10.1172/JCI200319246
|
[20]
|
Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A. and Chen, H. (2003) Chronic Inflammation in Fat Plays A Crucial Role in the Development of Obesity-Related Insulin Resistance. Journal of Clinical Investigation, 112, 1821-1830. https://doi.org/10.1172/JCI200319451
|
[21]
|
Gao, D., Madi, M., Ding, C., Fok, M., Steele, T., Ford, C., Hunter, L. and Bing, C. (2014) Interleukin-1β Mediates Macrophage-Induced Impairment of Insulin Signaling in Human Primary Adipocytes. American Journal of Physiology-Endocrinology and Metabolism, 307, E289-E304. https://doi.org/10.1152/ajpendo.00430.2013
|
[22]
|
Ren, Y., Zhao, H., Yin, C., Lan, X., Wu, L., Du, X., Griffiths, H.R. and Gao, D. (2022) Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation. Frontiers in Endocrinology (Lausanne), 13, Article 873699. https://doi.org/10.3389/fendo.2022.873699
|
[23]
|
Muñoz-Garach, A., Cornejo-Pareja, I. and Tinahones, F.J. (2016) Does Metabolically Healthy Obesity Exist? Nutrients, 8, Article 320. https://doi.org/10.3390/nu8060320
|
[24]
|
Achari, A.E. and Jain, S.K. (2017) Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. International Journal of Molecular Sciences, 18, Article 1321. https://doi.org/10.3390/ijms18061321
|
[25]
|
Kumada, M., Kihara, S., Ouchi, N., Kobayashi, H., Okamoto, Y., Ohashi, K., Maeda, K., Nagaretani, H., Kishida, K., Maeda, N., Nagasawa, A., Funahashi, T. and Matsuzawa, Y. (2004) Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 through Interleukin-10 Expression in Human Macrophages. Circulation, 109, 2046-2049. https://doi.org/10.1161/01.CIR.0000127953.98131.ED
|
[26]
|
Takemura, Y., Ouchi, N., Shibata, R., Aprahamian, T., Kirber, M.T., Summer, R.S., Kihara, S. and Walsh, K. (2007) Adiponectin Modulates Inflammatory Reactions via Calreticulin Receptor-Dependent Clearance of Early Apoptotic Bodies. Journal of Clinical Investigation, 117, 375-386. https://doi.org/10.1172/JCI29709
|
[27]
|
Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., Akasaki, Y., Shimono, A. and Walsh, K. (2010) Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity. Science, 329, 454-457.
https://doi.org/10.1126/science.1188280
|
[28]
|
李海霞, 魏静, 哈小琴. 抗炎性脂肪因子分泌型卷曲相关蛋白5参与炎性疾病的研究进展[J]. 中国生物制品学志, 2022, 35(5): 621-625+631. https://doi.org/10.13200/j.cnki.cjb.003609
|
[29]
|
Tong, S., Ji, Q., Du, Y., Zhu, X., Zhu, C. and Zhou, Y. (2019) Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease. Journal of Interferon & Cytokine Research, 39, 472-482.
https://doi.org/10.1089/jir.2018.0154
|
[30]
|
Karelis, A.D. and Rabasa-Lhoret, R. (2013) Obesity: Can Inflammatory Status Define Metabolic Health? Nature Reviews Endocrinology, 9, 694-695. https://doi.org/10.1038/nrendo.2013.198
|
[31]
|
Appleton, S.L., Seaborn, C.J., Visvanathan, R., Hill, C.L., Gill, T.K., Taylor, A.W. and Adams, R.J, North West Adelaide Health Study Team (2013) Diabetes and Cardiovascular Disease Outcomes in the Metabolically Healthy Obese Phenotype: A Cohort Study. Diabetes Care, 36, 2388-2394. https://doi.org/10.2337/dc12-1971
|
[32]
|
Phillips, C.M. (2013) Metabolically Healthy Obesity: Definitions, Deter-minants and Clinical Implications. Reviews in Endocrine and Metabolic Disorders, 14, 219-227. https://doi.org/10.1007/s11154-013-9252-x
|
[33]
|
Lynch, L.A., O’Connell, J.M., Kwasnik, A.K., Cawood, T.J., O’Farrelly, C. and O’Shea, D.B. (2009) Are Natural Killer Cells Protecting the Metabolically Healthy Obese Patient? Obesity (Silver Spring), 17, 601-605.
https://doi.org/10.1038/oby.2008.565
|